paraplegia: Complete paralysis of the lower half of the body including both legs, often caused by damage to the spinal cord. [database_cross_reference: NCIT:P378]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
802 |
4. Check minimum number of eventsNone |
802 |
5. Include endpointsNone |
802 |
6. Filter based on genotype QC (FinnGen only) |
802 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Paraplegia, diplegia of upper limbs
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7688 | 3418 | 4167 |
| Only index persons | 6093 | 2826 | 3267 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.10 | 0.12 |
| Only index persons | 0.12 | 0.10 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 56.92 | 57.26 | 56.41 |
| Only index persons | 54.02 | 54.33 | 53.75 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 802 | 362 | 440 |
| Unadjusted period prevalence (%) | 0.16 | 0.12 | 0.19 |
| Median age at first event (years) | 54.09 | 47.41 | 59.58 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 734
- Matched controls
- 7339
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
323.0
548
*
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
146.9
136
*
G82.0
ICD-10 Finland
Flaccid paraplegia
+∞
118.0
110
*
M03BX01
ATC
baclofen; systemic
48.2
113.6
138
35
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
412.0
109.4
107
*
L89
ICD-10 Finland
Decubitus ulcer and pressure area
42.4
89.9
112
31
N18
ICPC
Paralysis/weakness
28.0
78.2
108
45
XKD06
NOMESCO Finland
Physiologic investigation of micturition
18.0
76.9
123
81
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
176.7
76.7
79
5
XKC03
NOMESCO Finland
Water cystometry
16.3
71.1
118
85
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
47.7
63.4
77
18
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
19.6
60.4
93
54
R33
ICD-10 Finland
Retention of urine
6.4
57.6
166
318
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
21.0
57.4
86
46
N03AX16
ATC
pregabalin; oral
4.0
55.9
283
991
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
33.1
54.9
72
24
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.6
53.3
216
608
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
5.0
53.0
196
501
SPAT1229
SPAT
Assessment of need for aid
6.4
52.1
149
280
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
32.8
50.3
66
22
L28
ICPC
Limited function/disability (L)
4.5
49.5
206
590
UKC02
NOMESCO Finland
Cystoscopy
4.1
48.5
225
712
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.0
46.0
121
201
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
5.8
45.9
141
287
TKC20
NOMESCO Finland
Catheterisation of bladder
6.5
45.4
127
229
N03AX12
ATC
gabapentin; oral
4.2
44.5
199
602
J01MA12
ATC
levofloxacin; systemic
3.6
41.6
223
784
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
4.1
41.0
184
554
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.7
41.0
210
710
J01EA01
ATC
trimethoprim; systemic
3.3
40.7
257
1023
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
18.7
40.1
62
36
G82.5
ICD-10 Finland
Tetraplegia, unspecified
+∞
40.0
38
*
R1250
NOMESCO Finland
Evaluation of functional capability
15.4
39.0
65
46
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
13.0
38.4
69
58
TAB00
NOMESCO Finland
Lumbar puncture
8.2
38.2
89
122
N03AE01
ATC
clonazepam; systemic
6.2
37.8
108
198
QBG10
NOMESCO Finland
Excision and repair of bedsore of trunk
133.4
36.0
38
*
A28
ICPC
Limited function/disability NOS
3.6
33.9
179
606
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
15.1
33.4
56
40
T91.1
ICD-10 Finland
Sequelae of fracture of spine
51.3
32.8
39
8
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.3
32.5
132
356
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
6.3
32.5
90
158
A06AD11
ATC
lactulose; oral
3.6
32.3
169
568
WX408
NOMESCO Finland
General anesthesy, balanced
2.7
30.3
267
1276
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
71.1
30.1
34
5
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
21.2
29.9
44
22
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.4
29.3
160
552
N02AA05
ATC
oxycodone; systemic
3.3
29.2
168
603
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
14.0
29.1
50
38
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
14.1
28.6
49
37
S97
ICPC
Chronic ulcer skin
5.4
28.6
91
189
AA1AD
NOMESCO Finland
CT of head and brain
2.7
28.2
234
1069
J01MA02
ATC
ciprofloxacin; systemic
2.4
27.5
342
1948
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.7
27.2
97
228
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.8
26.9
124
371
N02AX02
ATC
tramadol; systemic, rectal
2.4
26.9
363
2144
G95.1
ICD-10 Finland
Vascular myelopathies
145.3
26.8
28
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.5
26.8
137
447
A46
ICD-10 Finland
Erysipelas
3.2
26.6
156
564
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
15.0
26.5
44
31
N30.0
ICD-10 Finland
Acute cystitis
3.4
26.4
143
486
G82.4
ICD-10 Finland
Spastic tetraplegia
+∞
26.2
25
*
S24.0
ICD-10 Finland
Concussion and oedema of thoracic spinal cord
269.6
25.9
26
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.6
25.7
228
1074
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
25.6
204
901
N30.9
ICD-10 Finland
Cystitis, unspecified
5.6
24.7
74
143
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
19.4
24.6
37
20
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
25.4
24.6
34
14
J01CA08
ATC
pivmecillinam; oral
2.4
24.5
287
1561
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.1
24.4
102
279
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
6.3
24.2
66
113
M48.0
ICD-10 Finland
Spinal stenosis
3.3
24.1
133
457
34401
ICD-8 Finland
Other cerebral paralysis, Diplegia NUD
+∞
24.1
23
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.1
24.0
67
118
XKD03
NOMESCO Finland
Urethral pressure profilometry
9.1
24.0
51
60
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
23.8
262
1374
SPAT1262
SPAT
Handing over of treatment supplies
2.7
23.8
191
841
G83.4
ICD-10 Finland
Cauda equina syndrome
89.8
23.8
26
*
QBG00
NOMESCO Finland
Debridement of bedsore of trunk
89.8
23.8
26
*
N28
ICPC
Limited function/disability (N)
10.6
23.6
46
46
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
23.0
22
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
17.1
22.9
36
22
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
22.4
152
601
R4120
NOMESCO Finland
Occupational therapy
4.4
22.3
84
208
C03CA01
ATC
furosemide; systemic
2.3
22.2
256
1364
G35
ICD-10 Finland
Multiple sclerosis
12.8
22.0
39
32
R4110
NOMESCO Finland
Physiotherapy
2.4
21.8
239
1239
U07
ICPC
Urine symptom/complaint other
4.6
21.7
78
184
N29
ICPC
Neurological sympt/complt other
11.1
21.6
41
39
N99
ICPC
Neurological disease other
14.5
21.5
36
26
SPAT1231
SPAT
Assessment of adjustments needed in living environment
8.0
21.4
49
65
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
7.8
21.0
49
67
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.7
21.0
74
171
G95.9
ICD-10 Finland
Disease of spinal cord, unspecified
61.9
21.0
24
*
G04BD08
ATC
solifenacin; oral
4.3
20.9
80
201
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.0
20.9
88
242
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
20.9
260
1430
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
20.8
159
676
ABD40
NOMESCO Finland
Implantation of spinal injection device
215.8
20.7
21
*
N06AA09
ATC
amitriptyline; systemic
3.3
20.7
113
382
N06AX21
ATC
duloxetine; oral
3.4
20.5
107
351
XF400
NOMESCO Finland
ECG with 12 standard connections
2.6
20.5
168
742
SPAT1167
SPAT
Insertion of urinary catheter
5.7
20.4
60
113
N05BA01
ATC
diazepam; systemic, rectal
2.9
20.4
138
542
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.2
20.0
64
133
N81
ICPC
Injury nervous system other
36.9
19.9
25
7
G04AC01
ATC
NA
7.6
19.6
46
64
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
19.4
125
474
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
26.9
19.2
26
10
SPAT1216
SPAT
Assessment of functional ability
2.7
19.2
145
609
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
56.6
19.0
22
*
J01MA06
ATC
norfloxacin; oral
2.9
19.0
125
482
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
18.9
158
701
J01XX05
ATC
methenamine; oral
24.4
18.7
26
11
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
102.7
18.6
20
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
6.4
18.5
49
81
G04BD04
ATC
oxybutynin; oral, transdermal
4.5
18.4
67
160
R20.2
ICD-10 Finland
Paraesthesia of skin
4.0
18.3
76
206
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
20.0
18.3
27
14
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.8
18.3
62
138
A41.9
ICD-10 Finland
Sepsis, unspecified
5.2
18.2
57
116
NAJ22
NOMESCO Finland
Posterior reduction of fractrue of thoracic spine
33.8
18.0
23
7
G95.0
ICD-10 Finland
Syringomyelia and syringobulbia
33.8
18.0
23
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
18.0
115
433
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
23.5
17.8
25
11
G83.0
ICD-10 Finland
Diplegia of upper limbs
+∞
17.8
17
*
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
+∞
17.8
17
*
G61.0
ICD-10 Finland
Guillain-Barré syndrome
37.7
17.7
22
6
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
37.7
17.7
22
6
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
17.3
110
413
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.4
17.2
52
102
R60.0
ICD-10 Finland
Localized oedema
3.0
17.1
106
391
NAJ32
NOMESCO Finland
Posterior reduction of fractrue of lumbar spine
64.9
16.8
19
*
XKD00
NOMESCO Finland
Uroflowmetry
2.4
16.7
158
748
J01XE01
ATC
nitrofurantoin; oral
9.3
16.6
34
38
ZZR10
NOMESCO Finland
Flap of skin and muscle
20.6
16.5
24
12
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
16.5
93
322
X59
ICD-10 Finland
Exposure to unspecified factor
2.3
16.1
169
839
R31
ICD-10 Finland
Unspecified haematuria
2.9
15.8
106
410
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
8.1
15.7
35
45
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
87.0
15.6
17
*
W19
ICD-10 Finland
Unspecified fall
3.0
15.4
94
343
109
Kela drug reimbursment
Multiple sclerosis
11.6
15.4
28
25
SPAT1255
SPAT
Intravenous administration of medicine
3.5
15.4
73
222
S72.4
ICD-10 Finland
Fracture of lower end of femur
16.5
15.3
24
15
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.8
15.2
67
191
J01FF01
ATC
clindamycin; systemic
2.1
15.2
220
1257
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.0
15.2
91
327
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.0
15.2
42
74
G99.2
ICD-10 Finland
Myelopathy in diseases classified elsewhere
20.6
15.2
22
11
N06AX16
ATC
venlafaxine; oral
2.6
15.2
119
507
U05
ICPC
Urination problems other
4.2
15.2
59
151
K59.0
ICD-10 Finland
Constipation
4.0
15.1
61
162
W17
ICD-10 Finland
Other fall from one level to another
4.2
15.1
58
147
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
57.9
14.8
17
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
14.8
121
525
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.5
14.7
131
595
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
14.7
76
247
9072A
ICD-9 Finland
Late effects of injuries to the nervous system, Late effect of spinal cord injury
+∞
14.6
14
*
F44.4
ICD-10 Finland
Dissociative motor disorders
+∞
14.6
14
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
14.6
99
386
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.4
14.6
72
226
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.9
14.6
61
167
N06AB04
ATC
citalopram; systemic
2.2
14.5
176
929
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
19.6
14.3
21
11
WX002
NOMESCO Finland
Sedation and analgesia
2.2
14.3
163
836
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
5.2
14.2
44
89
U04
ICPC
Incontinence urine
4.1
14.1
55
141
R53
ICD-10 Finland
Malaise and fatigue
2.2
14.1
164
848
G04BD12
ATC
mirabegron; oral
2.9
14.1
90
339
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
9.3
13.8
28
31
Z43.5
ICD-10 Finland
Attention to cystostomy
13.9
13.8
23
17
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
76.6
13.6
15
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
13.6
165
870
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
13.5
222
1323
NA2AD
NOMESCO Finland
Thoracic spine CT examination
16.6
13.5
21
13
QDG10
NOMESCO Finland
Excision and repair of bedsore of lower limb
142.5
13.5
14
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.9
13.4
44
95
G99.2*M47.9
ICD-10 Finland
Myelopathy in spondylosis
26.3
13.4
18
7
U13
ICPC
Bladder symptom/complaint other
5.8
13.3
37
66
N03AF02
ATC
oxcarbazepine; oral
5.3
13.2
40
79
R52.2
ICD-10 Finland
Other chronic pain
4.8
13.2
44
97
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.0
13.1
53
141
B01AB05
ATC
enoxaparin; parenteral
1.9
13.0
229
1396
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
13.0
63
195
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
13.3
13.0
22
17
U29
ICPC
Urinary symptom/complaint other
5.2
13.0
40
81
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
12.9
94
383
V89
ICD-10 Finland
Motor- or nonmotor-vehicle accident, type of vehicle unspecified
50.9
12.9
15
*
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.1
12.7
34
58
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
6.8
12.6
31
47
SPAT1254
SPAT
Administration of medicine
2.3
12.6
128
622
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.4
12.5
45
107
G81.1
ICD-10 Finland
Spastic hemiplegia
+∞
12.5
12
*
3499X
ICD-9 Finland
Other and unspecified disorders of the nervous system, Unspecified disorders of nervous system
+∞
12.5
12
*
S34.0
ICD-10 Finland
Concussion and oedema of lumbar spinal cord
+∞
12.5
12
*
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
4.3
12.4
46
113
TKC22
NOMESCO Finland
Catheterisation instruction
5.9
12.4
34
60
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.6
12.3
55
160
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
12.2
217
1321
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.3
12.1
120
572
R5110
SPAT
NA
5.5
12.1
35
66
R15
ICD-10 Finland
Faecal incontinence
5.8
11.9
33
59
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.0
11.9
70
250
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
11.8
93
394
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.7
11.8
52
149
N05CF01
ATC
zopiclone; oral
1.8
11.7
242
1553
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
66.0
11.6
13
*
NA7DM
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with 3 Tesla magnet
66.0
11.6
13
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.3
11.6
42
101
N21.0
ICD-10 Finland
Calculus in bladder
9.5
11.6
23
25
G04BD07
ATC
tolterodine; oral
3.8
11.5
49
137
N86
ICPC
Multiple sclerosis
13.9
11.5
19
14
G82
ICD-10 Finland
Paraplegia and tetraplegia
+∞
11.5
11
*
G11.4
ICD-10 Finland
Hereditary spastic paraplegia
+∞
11.5
11
*
G99.2*M47.0
ICD-10 Finland
Anterior spinal and vertebral artery compression syndromes
121.8
11.5
12
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
11.4
161
897
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
11.4
118
575
J96.1
ICD-10 Finland
Chronic respiratory failure
5.4
11.3
33
63
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
11.2
63
216
N05AA02
ATC
levomepromazine; systemic
3.7
11.2
48
135
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
13.0
11.2
19
15
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
11.2
257
1701
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
5.5
11.1
32
60
R35
ICD-10 Finland
Polyuria
3.1
11.1
60
202
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
4.7
11.1
37
82
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.7
11.1
76
298
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.1
11.1
42
106
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.8
11.1
27
41
N03AF01
ATC
carbamazepine; oral, rectal
3.4
11.0
54
169
R50.9
ICD-10 Finland
Fever, unspecified
2.2
11.0
120
600
SPAT1263
SPAT
Sampling
1.7
10.9
309
2175
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
10.9
310
2186
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
12.2
10.9
19
16
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.0
10.9
62
216
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
15.8
10.9
17
11
XA402
NOMESCO Finland
ENMG
5.3
10.9
32
62
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.5
10.8
50
150
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
21.8
10.7
15
7
M03BX02
ATC
tizanidine; oral
1.7
10.7
424
3285
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
10.7
60
206
ABC63
NOMESCO Finland
Decompression of thoracic spinal cord
60.9
10.6
12
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
8.7
10.6
22
26
U71
ICPC
Cystitis/urinary infection other
3.1
10.6
57
192
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.8
10.6
44
121
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.5
10.5
24
33
NF3AA
NOMESCO Finland
Femur X-ray examination
6.0
10.5
28
48
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.5
606
5250
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
111.5
10.4
11
*
G83.1
ICD-10 Finland
Monoplegia of lower limb
111.5
10.4
11
*
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
+∞
10.4
10
*
80691
ICD-8 Finland
Fracture and fracture dislocation of vertebral column with spinal cord lesion, Thoracica, Sequelae
+∞
10.4
10
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
10.4
10
*
A08
ICPC
Swelling
3.7
10.4
44
123
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
33.0
10.4
13
*
204
Kela drug reimbursment
Leukemia lymphatica
5.0
10.3
32
66
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
19.1
10.3
15
8
JN4BD
NOMESCO Finland
Extensive body CT
2.4
10.3
92
418
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
10.2
39
100
TQW11
NOMESCO Finland
Vacuum treatment of wound
5.3
10.1
30
59
SPAT1301
SPAT
No procedures
1.8
10.1
230
1509
S82.1
ICD-10 Finland
Fracture of upper end of tibia
6.4
9.9
25
40
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
8.9
9.8
20
23
S22.1
ICD-10 Finland
Multiple fractures of thoracic spine
20.3
9.8
14
7
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.8
9.8
18
17
Z50.1
ICD-10 Finland
Other physical therapy
3.2
9.8
51
168
N30.2
ICD-10 Finland
Other chronic cystitis
13.6
9.7
16
12
NF1AA
NOMESCO Finland
Hip X-ray examination
2.6
9.7
71
290
N30
ICD-10 Finland
Cystitis
2.9
9.6
57
205
K59.09
ICD-10 Finland
Constipation, unspecified
3.1
9.6
54
185
R32
ICD-10 Finland
Unspecified urinary incontinence
4.8
9.6
31
67
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.4
9.6
45
137
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
7.3
9.6
22
31
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
9.5
61
231
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
5.7
9.4
26
47
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
30.4
9.4
12
*
RK112
NOMESCO Finland
NA
+∞
9.4
9
*
S24.1
ICD-10 Finland
Other and unspecified injuries of thoracic spinal cord
+∞
9.4
9
*
G83.8
ICD-10 Finland
Other specified paralytic syndromes
+∞
9.4
9
*
A211_
NOMESCO Finland
NA
+∞
9.4
9
*
R51.80
ICD-10 Finland
Headache
2.1
9.4
110
564
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
9.4
84
383
R06.0
ICD-10 Finland
Dyspnoea
1.8
9.3
179
1108
G04AA01
ATC
NA
9.7
9.3
18
19
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
6.2
9.3
24
40
G04BE03
ATC
sildenafil; oral
6.2
9.3
24
40
R13
ICD-10 Finland
Dysphagia
2.9
9.3
57
208
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.2
123
667
Z04.3
ICD-10 Finland
Examination and observation following other accident
5.1
9.2
28
57
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.1
9.2
28
57
B01AA03
ATC
warfarin; systemic
1.9
9.2
154
909
N06AX11
ATC
mirtazapine; oral
1.7
9.2
217
1434
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
9.1
81
365
SPAT1234
SPAT
Support of social functional capacity
3.0
9.0
51
176
NA3CM
NOMESCO Finland
Lumbar spine extensive MRI examination with 3 Tesla magnet
24.3
8.9
12
5
G99.2*M51.0
ICD-10 Finland
Lumbar and other intervertebral disc disorders with myelopathy
24.3
8.9
12
5
QBA10
NOMESCO Finland
Incision of skin of trunk
9.6
8.8
17
18
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.7
8.8
60
236
J01CF05
ATC
flucloxacillin; systemic
3.7
8.8
37
104
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
8.8
84
393
WX725
NOMESCO Finland
Noninvasive ventilation
3.2
8.7
45
148
RS142
NOMESCO Finland
NA
50.6
8.7
10
*
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
3.2
8.7
44
143
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.9
8.6
23
40
WX892
NOMESCO Finland
Monitored bed care
2.5
8.6
68
290
M79.6
ICD-10 Finland
Pain in limb
1.7
8.6
241
1667
L03AB07
ATC
interferon beta-1a; parenteral
10.2
8.6
16
16
M54.5
ICD-10 Finland
Low back pain
1.7
8.5
226
1539
NA1CM
NOMESCO Finland
Cervical spine extensive MRI examination with 3 Tesla magnet
27.9
8.5
11
*
KH1AT
NOMESCO Finland
Urinary tract cathetrisation with ultrasound guidance
27.9
8.5
11
*
S76
ICPC
Skin infection other
3.1
8.5
45
151
6BA02
NOMESCO Finland
NA
20.3
8.5
12
6
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.3
8.5
30
72
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.7
8.4
35
97
ZZA00
NOMESCO Finland
Split skin graft
4.0
8.4
32
82
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.6
8.4
28
63
RJ630
NOMESCO Finland
NA
91.1
8.4
9
*
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
+∞
8.3
8
*
AEA30
NOMESCO Finland
Replacement of implanted pump of injection device in the nervous system
+∞
8.3
8
*
Q82.2
ICD-10 Finland
Mastocytosis
+∞
8.3
8
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
8.3
8
*
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
8.3
40
125
UJF32
NOMESCO Finland
Coloscopy
1.7
8.3
178
1135
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
10.9
8.3
15
14
N03AX09
ATC
lamotrigine; oral
3.2
8.3
43
142
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.6
8.3
60
244
RS222
NOMESCO Finland
NA
7.2
8.3
19
27
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.6
8.3
36
104
N05AH04
ATC
quetiapine; oral
2.0
8.3
116
640
A04
ICPC
Weakness/tiredness general
2.1
8.2
98
508
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.1
8.2
100
523
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
8.3
8.1
17
21
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
8.3
8.1
17
21
ABC53
NOMESCO Finland
Decompression of thoracic spinal canal and nerve roots
33.7
8.1
10
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
8.1
43
145
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
10.2
8.1
15
15
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.0
89
447
N05BA04
ATC
oxazepam; oral
1.7
8.0
171
1086
A82
ICPC
Secondary effect of trauma
22.3
8.0
11
5
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
8.0
86
423
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
8.0
54
209
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.0
8.0
45
156
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
7.9
7.9
17
22
R11
ICD-10 Finland
Nausea and vomiting
2.5
7.9
63
269
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.7
7.8
53
207
R52.1
ICD-10 Finland
Chronic intractable pain
9.5
7.8
15
16
X58
ICD-10 Finland
Exposure to other specified factors
2.0
7.8
105
571
A01
ICPC
Pain general/multiple sites
2.4
7.8
63
273
WX882
NOMESCO Finland
High dependency care
3.6
7.8
33
94
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
4.2
7.8
28
69
L81
ICPC
Injury musculoskeletal NOS
4.7
7.7
25
55
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.7
7.7
25
55
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.0
7.7
29
74
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
7.7
147
901
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
15.2
7.7
12
8
RS314
NOMESCO Finland
NA
45.5
7.7
9
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
45.5
7.7
9
*
G95.2
ICD-10 Finland
Cord compression, unspecified
45.5
7.7
9
*
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.0
7.7
20
34
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.1
7.7
40
133
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
7.7
163
1033
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.1
7.6
28
70
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
18.6
7.6
11
6
KDV20
NOMESCO Finland
Submucous urethral injection
25.3
7.6
10
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.2
7.6
27
66
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.9
7.5
29
76
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.4
7.5
34
102
L17
ICPC
Foot/toe symptom/complaint
1.7
7.5
169
1091
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.3
7.4
71
333
1601
FHL
Cystometry
80.9
7.4
8
*
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
80.9
7.4
8
*
B91
ICD-10 Finland
Sequelae of poliomyelitis
80.9
7.4
8
*
SPAT1211
SPAT
Application of soft bandage
2.3
7.4
68
312
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
7.4
49
191
R39.1
ICD-10 Finland
Other difficulties with micturition
3.6
7.4
31
88
D17
ICPC
Incontinence of bowel
8.5
7.3
15
18
A02BC01
ATC
omeprazole; systemic
1.7
7.3
185
1233
Z02.7
ICD-10 Finland
Issue of medical certificate
2.6
7.3
51
204
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
9.5
7.3
14
15
G83.3
ICD-10 Finland
Monoplegia, unspecified
+∞
7.3
7
*
G06.1
ICD-10 Finland
Intraspinal abscess and granuloma
+∞
7.3
7
*
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
+∞
7.3
7
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.3
127
754
G04BD09
ATC
trospium; oral
4.3
7.3
25
59
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.4
7.3
62
275
R5599
NOMESCO Finland
Other rehabilitation service
3.8
7.2
29
79
N30.1
ICD-10 Finland
Interstitial cystitis (chronic)
7.4
7.2
16
22
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
30.3
7.2
9
*
RF310
NOMESCO Finland
NA
30.3
7.2
9
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
30.3
7.2
9
*
M41.5
ICD-10 Finland
Other secondary scoliosis
30.3
7.2
9
*
RK220
NOMESCO Finland
NA
20.2
7.1
10
5
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
20.2
7.1
10
5
ABD99
NOMESCO Finland
Other operation on spinal cord or nerve for pain or impaired function
20.2
7.1
10
5
RS122
NOMESCO Finland
NA
20.2
7.1
10
5
Z73.6
ICD-10 Finland
Limitation of activities due to disability
6.7
7.1
17
26
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.0
7.1
39
135
ZX120
NOMESCO Finland
Intravenous
2.1
7.1
80
403
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.1
7.1
18
30
G99.2*M50.0
ICD-10 Finland
Cervical disc disorder with myelopathy
12.2
7.1
12
10
V29.9
ICD-10 Finland
Motorcycle rider [any] injured in unspecified traffic accident
7.1
7.0
16
23
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.3
6.9
60
269
A03
ICPC
Fever
1.9
6.9
109
628
NFQ20
NOMESCO Finland
Amputation of femur
8.4
6.8
14
17
L03AX13
ATC
glatiramer acetate; parenteral
11.1
6.8
12
11
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.0
6.8
37
128
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
6.8
123
739
GBB00
NOMESCO Finland
Tracheostomy
5.7
6.8
18
32
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
6.8
64
299
N05CD07
ATC
temazepam; oral
1.9
6.8
92
503
ABB20
NOMESCO Finland
Drainage of intra- or extramedullary cyst of spinal canal
40.4
6.8
8
*
Z93.5
ICD-10 Finland
Cystostomy status
40.4
6.8
8
*
N07BC02
ATC
methadone; systemic
16.9
6.8
10
6
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
16.9
6.8
10
6
J01CE08
ATC
benzathine benzylpenicillin; parenteral
7.3
6.7
15
21
J01DA01
ATC
[U] cefalexin; systemic
1.5
6.7
420
3458
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
5.0
6.7
20
41
F61.0
ICD-10 Finland
Mixed personality disorders
6.5
6.7
16
25
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
6.7
125
760
U28
ICPC
Limited function/disability (U)
6.0
6.6
17
29
SPAT1127
SPAT
Enema
7.9
6.6
14
18
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.9
6.6
14
18
L03.9
ICD-10 Finland
Cellulitis, unspecified
4.7
6.6
21
46
WX702
NOMESCO Finland
Supraglottic ventilation device
2.7
6.6
43
166
A29
ICPC
General symptom/complaint other
2.0
6.6
81
426
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.2
6.6
33
108
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
10.1
6.5
12
12
Z75.5
ICD-10 Finland
Holiday relief care
10.1
6.5
12
12
ZZR00
NOMESCO Finland
Flap of skin
4.2
6.5
23
56
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
6.9
6.5
15
22
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
4.0
6.5
24
61
UJH02
NOMESCO Finland
Anoscopy
3.0
6.5
37
129
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.3
6.5
57
255
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.1
6.5
33
109
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
6.3
6.5
16
26
Z71.8
ICD-10 Finland
Other specified counselling
1.7
6.5
157
1032
G83.2
ICD-10 Finland
Monoplegia of upper limb
70.4
6.4
7
*
NAW10
NOMESCO Finland
Reoperation for superficial infection in in surgery of spine or neck
70.4
6.4
7
*
G37.3
ICD-10 Finland
Acute transverse myelitis in demyelinating disease of central nervous system
70.4
6.4
7
*
9222
FHL
Surgery for a fresh back injury
70.4
6.4
7
*
NA7FT
NOMESCO Finland
Labeling lesion in spinal area with X-ray guidance
70.4
6.4
7
*
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
70.4
6.4
7
*
SPAT1125
SPAT
Stoma care and guidance
4.5
6.4
21
48
RK110
NOMESCO Finland
NA
8.2
6.3
13
16
S29
ICPC
Skin symptom/complaint other
1.8
6.3
113
678
XG466
NOMESCO Finland
Sleep oxymetry
3.2
6.3
31
100
M05BX04
ATC
denosumab; parenteral
2.9
6.3
37
134
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
6.3
72
365
N30.8
ICD-10 Finland
Other cystitis
11.1
6.3
11
10
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
11.1
6.3
11
10
S72.2
ICD-10 Finland
Subtrochanteric fracture
11.1
6.3
11
10
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.4
6.3
53
233
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
9.4
6.3
12
13
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
9.4
6.3
12
13
NAG41
NOMESCO Finland
Anterior fusion of cervical spine with fixation
9.4
6.3
12
13
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
6.3
6
*
5965X
ICD-9 Finland
Other disorders of bladder, Other functional disorders of bladder[ALIA FUNCTIO LAESA VESICAE URINARIAE]
+∞
6.3
6
*
C41.29
ICD-10 Finland
Malignant tumor of the spine other or unspecified histology
+∞
6.3
6
*
D33.43
ICD-10 Finland
Spinal cord
+∞
6.3
6
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
6.3
6
*
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
+∞
6.3
6
*
C41.20
ICD-10 Finland
Malignant tumor of the spine without histology
+∞
6.3
6
*
NA7CM
NOMESCO Finland
Spine and spinal cord extensive MRI examination with 3 Tesla magnet
+∞
6.3
6
*
T09.3
ICD-10 Finland
Injury of spinal cord, level unspecified
+∞
6.3
6
*
T91.8
ICD-10 Finland
Sequelae of other specified injuries of neck and trunk
26.9
6.2
8
*
RF120
NOMESCO Finland
NA
6.4
6.2
15
24
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.1
6.2
31
102
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
6.2
221
1603
L03AB08
ATC
interferon beta-1b; parenteral
12.6
6.1
10
8
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
12.6
6.1
10
8
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.2
6.1
29
92
S70.0
ICD-10 Finland
Contusion of hip
3.1
6.0
31
104
WX730
NOMESCO Finland
Conventional respirator
6.1
6.0
15
25
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.0
6.0
32
110
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.0
57
269
L29
ICPC
Musculoskeletal sympt/complt other
2.2
6.0
57
269
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044290) Cell count panel - Cerebral spinal fluid
88
121
8.05
61.74
1.8
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
392
1800
3.30
60.25
7.5
2.9
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
93
149
6.93
56.79
1.6
1.4
mg/l
902.8
455.0
2.76
84
139
(3016018) Differential panel - Cerebral spinal fluid
57
51
11.96
54.97
1.9
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
39
13.03
49.08
1.1
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
366
1778
2.95
48.38
7.8
4.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
81
134
6.61
47.81
1.6
1.4
mmol/l
3.8
3.8
0.07
75
124
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
74
130
6.17
41.05
1.8
1.4
e6/l
35.7
11.7
0.60
54
102
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
74
130
6.17
41.05
1.8
1.5
e6/l
456.1
1459.5
0.49
54
106
(3023410) Appearance of Cerebral spinal fluid
49
56
9.25
39.65
2.0
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
193
762
3.02
35.66
3.8
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
46
56
8.65
35.40
1.2
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
228
1019
2.73
33.15
4.0
3.4
mmol/l
0.8
0.8
0.77
207
947
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
47
64
7.74
32.96
1.1
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
345
1914
2.41
31.44
2.7
2.1
u/l
217.1
304.4
0.75
328
1802
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
45
63
7.51
30.79
1.2
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
433
2696
2.32
29.68
6.1
4.8
g/l
33.2
35.5
10.40
404
2505
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
444
2841
2.26
27.89
9.2
5.9
mmol/l
1.2
1.2
2.16
414
2562
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
81
213
4.12
27.88
2.2
2.5
ug/l
221.3
500.7
0.74
74
202
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
469
3100
2.24
26.79
9.7
6.7
mmol/l
1.2
1.2
1.60
409
2606
(3026782) Osmolality of Urine
246
1245
2.41
26.78
5.4
2.9
mosm/kgh2o
528.5
566.2
2.30
222
1060
(3000850) Epithelial cells [#/volume] in Urine
255
1313
2.38
26.68
5.1
2.6
e6/l
4.4
5.4
0.67
233
1156
(42870588) Differential panel, method unspecified - Blood
355
2104
2.23
26.54
8.5
5.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
186
832
2.61
26.34
6.2
5.5
mmol/l
1.1
1.0
0.93
168
766
(3042936) Bacteria identified in Isolate by Culture
201
936
2.53
26.16
3.4
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
214
1044
2.43
25.06
2.7
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
568
4130
2.29
24.71
11.0
4.2
e6/l
4148.8
1812.1
0.38
14
69
(3019069) Monocytes/100 leukocytes in Blood
445
2956
2.14
24.14
9.8
6.1
%
8.4
8.8
1.73
419
2769
(3002582) Erythrocytes [#/volume] in Urine
325
1916
2.17
24.04
7.3
3.2
e6/l
45.5
95.7
0.71
271
1482
(3006504) Eosinophils/100 leukocytes in Blood
442
2940
2.12
23.75
9.4
5.8
%
2.8
2.9
0.24
416
2735
(3022096) Basophils/100 leukocytes in Blood
431
2855
2.10
23.23
9.3
5.8
%
0.7
0.7
0.14
402
2666
(3002030) Lymphocytes/100 leukocytes in Blood
448
3023
2.09
22.83
9.5
6.0
%
25.6
27.7
3.36
420
2816
(3037467) Urinalysis macro (dipstick) panel - Urine
581
4349
2.22
22.25
8.7
4.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
298
1740
2.13
22.21
6.9
3.1
e6/l
0.4
0.4
0.32
246
1308
(3018095) Leukocytes [#/volume] in Urine
357
2231
2.08
22.21
8.6
3.7
e6/l
127.7
128.6
0.01
281
1586
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
115
445
2.85
21.35
7.4
3.8
kpa
5.5
5.2
2.46
108
416
(3044640) Blood type and Crossmatch panel - Blood
331
2041
2.06
21.07
4.0
2.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
437
2977
2.03
21.06
9.1
5.7
%
59.6
57.3
3.47
412
2793
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
57
6.37
20.80
1.8
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
113
440
2.83
20.71
7.5
3.8
ph
7.4
7.4
0.31
13
49
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
415
2.85
20.27
7.4
3.9
mmol/l
2.5
1.8
0.99
88
319
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
27
34
8.18
20.12
1.2
1.1
u/l
1.4
1.1
0.74
14
19
(36304419) Bacteria [Presence] in Urine
285
1687
2.07
20.07
7.1
3.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
91
320
3.08
20.01
5.7
4.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
43
89
5.05
19.87
9.6
5.9
mg/l
11.7
11.2
0.28
38
84
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
139
614
2.53
19.79
2.6
2.2
g/l
0.2
0.2
2.44
126
571
(4027681)
27
35
7.95
19.65
1.3
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
155
723
2.42
19.60
8.9
7.8
mmol/l
1.6
1.1
0.65
123
562
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
110
436
2.77
19.45
2.2
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
155
728
2.40
19.28
8.8
7.7
kpa
5.3
5.1
1.29
140
698
(3027801) Oxygen [Partial pressure] in Arterial blood
155
729
2.40
19.22
8.7
7.7
kpa
12.1
12.1
0.06
140
702
(3032080) INR in Blood by Coagulation assay
389
2603
1.96
19.10
11.6
9.2
inr
1.3
1.2
0.91
110
738
(3018677) aPTT in Platelet poor plasma by Coagulation assay
192
993
2.23
19.04
2.7
2.2
s
30.2
29.7
0.49
186
960
(3006315) Basophils [#/volume] in Blood
447
3142
1.95
18.90
8.8
5.7
e9/l
0.0
0.0
0.56
394
2722
(3001604) Monocytes [#/volume] in Blood
445
3129
1.95
18.73
8.7
5.7
e9/l
0.6
0.6
0.08
393
2698
(3004588) Protein electrophoresis panel - Serum or Plasma
102
401
2.77
18.28
1.7
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
262
1548
2.03
18.22
3.7
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
508
3755
1.96
18.21
8.1
4.7
mmol/l
6.7
6.7
0.14
483
3515
(3013115) Eosinophils [#/volume] in Blood
456
3255
1.93
18.11
9.0
5.9
e9/l
0.2
0.2
0.28
405
2865
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
376
2521
1.93
18.03
2.9
2.2
nmol/l
77.3
76.1
0.31
338
2251
(3020630) Protein [Mass/volume] in Serum or Plasma
116
492
2.59
17.88
1.9
2.7
g/l
65.7
66.9
0.74
105
449
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
25
9.02
17.73
1.9
1.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
265
1585
2.00
17.72
7.5
3.9
%
86.9
89.6
0.93
257
1551
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
58
168
3.64
17.34
1.9
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
448
3208
1.90
17.31
9.0
5.7
e9/l
1.8
1.9
1.24
395
2826
(3005719) IgG [Mass/volume] in Serum or Plasma
113
484
2.55
17.04
2.4
2.4
g/l
10.1
10.7
0.62
104
442
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
32
60
5.51
16.48
3.4
2.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
123
559
2.42
16.31
9.1
7.2
mmol/l
1.4
1.4
0.18
115
532
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
454
3315
1.85
15.98
7.6
6.4
umol/l
10.5
11.4
0.47
442
3150
(3016502) Oxygen saturation in Arterial blood
136
652
2.31
15.96
9.6
8.2
%
95.1
95.5
0.28
125
630
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
262
1610
1.93
15.88
2.8
2.1
mg/l
3.2
3.0
0.53
221
1374
(3035350) Ketones [Presence] in Urine by Test strip
426
3056
1.84
15.82
6.5
3.5
estimate
0.0
0.0
0.00
91
568
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
74
267
2.95
15.49
3.0
2.1
ug/l
3.6
2.6
0.12
63
238
(3027945) Reticulocytes/100 erythrocytes in Blood
142
702
2.24
15.46
2.7
2.5
%
1.8
1.8
0.22
125
634
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
191
1065
2.04
15.22
5.4
2.7
e6/l
1.3
1.0
0.35
127
615
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
184
1013
2.06
15.18
6.2
2.9
e6/l
2.3
2.2
0.05
120
564
(3013650) Neutrophils [#/volume] in Blood by Automated count
484
3642
1.83
15.07
11.8
9.0
e9/l
4.4
4.1
1.61
434
3185
(3021447) Carbon dioxide [Partial pressure] in Venous blood
124
585
2.32
15.06
6.0
3.9
kpa
6.1
5.8
1.89
119
568
(3021601) Nitrite [Presence] in Urine by Test strip
422
3048
1.81
15.05
8.9
4.8
estimate
0.0
0.0
0.50
88
576
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
34
6.93
14.92
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
425
3087
1.80
14.77
6.7
3.5
estimate
0.0
0.0
0.50
92
546
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
16
15
10.86
14.68
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
38
6.48
14.62
1.2
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
82
324
2.71
14.49
8.8
10.5
mmol/l
24.7
24.5
0.19
75
305
(3003181) Sodium [Moles/volume] in Urine
40
102
4.07
14.30
1.6
1.2
mmol/l
57.6
64.4
0.49
26
87
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
16
16
10.18
14.06
1.1
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
121
583
2.27
13.94
6.1
3.9
mmol/l
2.1
1.8
0.34
105
464
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
77
303
2.70
13.71
7.1
4.1
mmol/l
24.4
24.0
0.42
70
282
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
134
678
2.17
13.68
4.4
4.2
u/l
293.7
245.1
0.37
124
641
(3000991) Gas panel - Venous blood
111
521
2.31
13.59
11.4
8.8
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
17
9.58
13.47
1.1
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
363
2569
1.75
13.34
2.4
2.0
pmol/l
90.2
94.6
1.02
212
1361
(3019309) Folate [Moles/volume] in Red Blood Cells
200
1183
1.92
13.24
1.9
1.7
nmol/l
1038.3
1186.4
1.51
150
894
(3023520) Reticulocytes [#/volume] in Blood
109
514
2.30
13.19
2.6
2.7
e9/l
69.7
69.2
0.06
83
402
(3002173) Hemoglobin [Mass/volume] in Arterial blood
120
594
2.20
12.91
10.0
8.7
g/l
120.4
121.8
0.27
112
574
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
91
401
2.43
12.82
2.1
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
306
2085
1.76
12.68
3.0
3.3
mmol/l
2.3
2.4
1.66
261
1828
(3045414) Leukocytes [Presence] in Urine
69
268
2.72
12.59
2.2
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
592
4866
1.83
12.44
10.9
7.6
u/l
85.3
78.6
2.56
568
4563
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
123
3.55
12.36
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
123
3.55
12.36
1.8
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
403
2982
1.71
12.28
6.0
4.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
42
124
3.52
12.21
2.0
1.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
113
558
2.19
12.20
6.5
7.5
mmol/l
10.3
9.9
0.19
108
532
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
63
239
2.78
12.02
2.4
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
92
420
2.34
11.97
6.9
4.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
258
2.70
11.90
2.7
1.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
14
15
9.48
11.68
1.1
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
274
1843
1.74
11.68
5.0
3.8
ph
7.4
7.4
0.72
58
339
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
226
2.79
11.61
1.8
2.5
g/l
7.9
7.2
1.46
43
173
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
226
2.79
11.61
1.8
2.5
g/l
4.0
3.8
0.42
42
164
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
226
2.79
11.61
1.8
2.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
145
809
1.97
11.25
11.1
6.9
mmol/l
103.3
104.2
1.23
139
790
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
134
728
2.01
11.21
2.6
1.8
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
15
6
25.42
11.17
1.1
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
214
2.79
11.10
1.8
2.6
g/l
3.3
3.1
1.10
42
167
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
17
8.36
10.64
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
53
197
2.81
10.52
1.8
2.8
g/l
0.6
1.1
0.69
46
176
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
93
452
2.20
10.41
3.7
3.9
ng/l
68.4
84.9
1.18
85
400
(3011397) Hemoglobin [Presence] in Urine by Test strip
219
1423
1.74
10.35
5.4
3.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
15
8
19.07
10.29
1.2
1.0
mg/g
13.0
6.7
—
15
8
(40758558) Short blood count panel - Blood
235
1560
1.72
10.27
10.4
6.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
143
820
1.91
10.17
1.4
1.3
titre
416.0
468.4
0.20
30
176
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
150
875
1.88
10.12
2.8
2.4
%
17.4
23.3
6.18
129
755
(3004789) Transferrin [Mass/volume] in Serum or Plasma
156
922
1.86
10.10
2.8
2.3
g/l
2.3
2.3
0.49
143
866
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
9
16.96
9.90
1.3
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
130
731
1.93
9.79
2.7
1.8
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
49
183
2.79
9.65
1.8
2.7
g/l
35.4
38.0
1.68
40
158
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
207
2.67
9.58
1.8
2.6
g/l
10.4
11.0
0.33
45
177
(3021901) Oxygen saturation in Capillary blood
37
118
3.24
9.57
4.6
2.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
65
4.10
9.57
1.1
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
11
10.13
9.56
1.1
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
11
10.13
9.56
1.2
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
48
179
2.79
9.48
9.9
2.5
mmol/l
26.1
24.7
1.31
42
157
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
118
649
1.96
9.47
4.9
3.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
33
99
3.43
9.40
3.8
3.4
%
2.0
1.3
0.32
22
82
(21494815) CD4 cells/100 lymphocytes in Specimen
22
49
4.59
9.35
3.1
1.8
%
45.7
34.1
—
6
7
(3022217) INR in Platelet poor plasma by Coagulation assay
139
814
1.86
9.21
24.7
23.1
inr
1.5
1.3
0.53
16
106
(3008295) Osmolality of Serum or Plasma
26
67
3.98
9.20
1.3
1.4
mosm/kgh2o
277.9
279.8
0.12
18
48
(3011412) CD3 cells [#/volume] in Blood
23
54
4.36
9.17
4.0
2.0
e9/l
1.2
1.1
0.18
12
26
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
179
1136
1.74
9.06
2.7
3.0
mmol/l
2.5
2.4
1.03
151
999
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
277
1974
1.62
8.99
2.9
2.6
u/l
49.9
56.4
3.44
259
1840
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
19
39
4.97
8.87
3.2
1.9
%
13.3
12.2
—
9
19
(3001122) Ferritin [Mass/volume] in Serum or Plasma
356
2698
1.57
8.87
3.4
2.7
ug/l
167.2
141.4
0.59
323
2485
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
16
28
5.81
8.83
1.3
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
37
125
3.05
8.72
3.1
2.2
%
15.8
16.5
0.48
21
63
(3024354) Oxygen [Partial pressure] in Venous blood
95
500
2.02
8.62
6.5
3.2
kpa
5.0
4.6
0.76
90
484
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
79
388
2.15
8.60
1.8
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
161
1005
1.75
8.60
2.9
2.3
umol/l
10.2
13.2
3.84
145
937
(3022621) pH of Urine by Test strip
79
394
2.11
8.27
3.8
2.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
60
268
2.34
8.20
1.5
2.1
u/l
32.9
39.3
1.53
55
239
(3036481) Cortisol [Moles/volume] in Serum or Plasma
103
568
1.93
8.17
2.1
2.0
nmol/l
312.0
382.6
3.24
92
517
(3028026) IgM [Mass/volume] in Serum or Plasma
78
393
2.09
7.96
1.9
1.6
g/l
1.1
1.5
1.64
73
364
(3021960) Folate [Moles/volume] in Serum or Plasma
217
1495
1.62
7.92
1.8
1.6
nmol/l
20.8
20.7
0.03
189
1261
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
60
273
2.29
7.87
1.8
1.8
g/l
1.8
1.5
1.29
51
239
(3008152) Bicarbonate [Moles/volume] in Arterial blood
79
402
2.07
7.85
11.7
7.0
mmol/l
26.0
24.3
2.70
69
376
(3017181) Myelocytes/100 leukocytes in Blood
95
517
1.95
7.83
4.1
4.2
%
1.3
0.9
0.56
34
171
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
325
2473
1.53
7.62
5.1
3.6
ng/l
212.2
54.6
0.48
263
1732
(3037756) Immunofixation for Serum or Plasma
36
130
2.85
7.58
1.4
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
136
2.80
7.54
4.0
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
23
63
3.73
7.50
3.8
3.5
%
62.2
53.1
0.76
13
46
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
37
4.67
7.43
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
37
4.67
7.43
1.5
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
87
468
1.96
7.42
4.0
4.1
%
1.4
0.4
0.88
23
127
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
179
2.54
7.37
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
68
337
2.11
7.25
11.5
11.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
34
4.78
7.19
2.8
2.0
—
—
—
0
0
(3019225) pH of Specimen
105
609
1.83
7.12
6.0
4.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
15
31
4.91
6.95
1.1
1.3
nmol/l
135.0
148.2
0.40
15
31
(3021440) Promyelocytes/100 leukocytes in Blood
88
487
1.91
6.90
4.1
4.3
%
0.2
0.1
0.10
30
155
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
40
4.32
6.77
1.2
2.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
250
1847
1.51
6.52
3.5
3.1
ng/l
1048.0
1383.7
1.10
223
1573
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
277
2091
1.50
6.51
4.5
3.3
u/l
30.4
33.4
0.87
262
1989
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
120
747
1.71
6.38
3.0
2.6
umol/l
8.4
7.9
0.07
102
657
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
42
4.11
6.38
1.1
1.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
17
42
4.11
6.38
1.3
1.3
u/l
5.5
6.5
0.34
11
32
(3034860) Kappa light chains.free [Mass/volume] in Serum
41
174
2.43
6.32
2.1
3.8
mg/l
739.0
93.7
0.45
36
144
(3025159) Blasts/100 leukocytes in Blood
82
457
1.88
6.30
4.0
4.4
%
0.0
0.1
0.83
24
135
(3007164) IgA [Mass/volume] in Serum or Plasma
179
1237
1.58
6.29
1.6
1.4
g/l
2.3
2.5
0.54
114
761
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
26
5.07
6.24
1.8
3.0
u/ml
606.5
581.2
0.06
13
26
(1761868) Lipid panel - Serum or Plasma
162
2287
0.63
6.18
3.0
2.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
79
439
1.89
6.12
4.9
2.8
e9/l
4.5
4.0
0.83
53
343
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
24
78
3.14
6.08
2.3
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
122
773
1.68
6.07
1.9
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
34
135
2.59
6.02
2.8
2.1
—
—
—
0
0
(4024509)
18
49
3.73
5.95
2.1
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
40
174
2.37
5.85
2.2
3.8
mg/l
42.5
52.3
0.23
35
145
(3029937) Albumin [Presence] in Urine by Test strip
224
1657
1.49
5.69
7.3
3.8
estimate
0.0
0.0
1.08
89
556
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
39
171
2.35
5.62
2.2
3.7
ratio
0.9
2.0
—
6
19
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
198
2.24
5.54
8.8
3.1
u/ml
0.3
0.4
0.96
22
108
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
25
4.86
5.51
1.2
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
20
62
3.28
5.48
1.1
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
539
4707
1.44
5.47
5.1
4.0
mm/h
16.0
11.9
5.75
501
4327
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
39
174
2.30
5.41
4.2
3.7
mg/l
1.6
1.6
0.21
32
159
(3036489) Thrombin time
47
227
2.14
5.39
3.6
2.4
s
21.3
21.7
0.15
41
203
(3008757) Leukocyte morphology finding [Identifier] in Blood
23
79
2.97
5.34
4.6
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
193
1404
1.49
5.27
2.4
1.8
mg/l
1.4
1.2
0.61
155
1075
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
22
5.06
5.27
1.4
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
86
515
1.75
5.24
2.9
2.9
ng/l
180.1
203.0
0.20
76
474
(3035637) Corticotropin [Mass/volume] in Plasma
20
64
3.18
5.22
1.8
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
21
70
3.05
5.13
2.6
1.9
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
8
6
13.45
5.08
1.0
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
50
3.45
5.05
4.1
1.9
e6/l
628.5
714.8
—
8
20
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
11
23
4.84
5.02
3.0
1.9
ug/l
94.2
86.2
0.07
11
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
46
227
2.09
5.01
2.9
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
183
1332
1.48
4.96
1.6
1.7
pmol/l
33553077.4
9736545.3
0.31
152
1099
(3021589) Normoblasts [#/volume] in Blood
342
2791
1.39
4.94
15.1
9.0
e9/l
0.0
0.0
0.41
284
2277
(3000330) Specific gravity of Urine by Test strip
58
313
1.92
4.94
3.9
3.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
62
3.11
4.81
1.5
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
7
11.53
4.79
1.3
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
187
1377
1.47
4.76
7.4
3.7
kg/l
1.0
1.0
1.66
36
183
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
35
158
2.27
4.75
2.3
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
104
2.55
4.58
1.5
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
34
3.87
4.55
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
34
3.87
4.55
1.5
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
295
2375
1.38
4.52
7.6
3.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
31
136
2.33
4.50
3.4
2.0
g/l
123.3
131.7
1.06
25
101
(3045424) Erythrocytes [Presence] in Urine
26
105
2.53
4.50
1.5
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
29
124
2.39
4.46
1.8
4.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
219
1685
1.41
4.36
6.9
3.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
132
2.32
4.34
3.1
3.5
mmol/l
3.2
2.4
0.47
24
87
(36660697) Celiac disease serology panel - Serum
76
466
1.70
4.28
1.2
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
20
73
2.78
4.21
2.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
574
6239
0.72
4.13
4.5
4.3
mmol/l
1.4
1.4
2.43
516
5724
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
20
74
2.75
4.11
2.0
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
20
74
2.75
4.11
2.0
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
39
196
2.04
4.09
7.5
7.1
mmol/l
1.7
1.3
0.71
28
170
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
10
8.07
4.06
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
10
8.07
4.06
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
13
37
3.55
4.06
5.3
2.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
20
75
2.71
4.01
2.0
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
20
75
2.71
4.01
2.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
20
75
2.71
4.01
2.0
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
7
10.07
4.01
1.1
1.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
21
82
2.60
3.91
1.8
2.2
pg
31.8
33.5
0.74
21
82
(3013512) EKG study
232
1836
1.37
3.84
4.8
3.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
15
6.05
3.82
1.2
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
107
734
1.53
3.82
1.8
1.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
8
8.81
3.78
1.3
1.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
12
34
3.57
3.78
2.7
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
12
34
3.57
3.78
2.7
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
12
34
3.57
3.78
2.7
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
34
3.57
3.78
2.7
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
594
6398
0.72
3.77
4.9
4.8
mmol/l
2.7
2.7
1.41
535
5869
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
91
606
1.57
3.71
3.3
2.4
u/l
26.4
32.9
1.91
79
517
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
48
269
1.83
3.70
6.5
5.6
%
2.4
1.6
1.91
41
254
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
84
550
1.59
3.68
3.6
2.3
ug/l
6.4
8.0
0.48
69
484
(3002619) Bacteria identified in Specimen by Culture
9
16
5.68
3.66
1.7
1.1
—
—
—
0
0
(4035726)
81
528
1.59
3.62
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
582
6276
0.74
3.57
4.6
4.3
mmol/l
4.5
4.6
2.35
526
5792
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
125
2.20
3.51
4.8
6.4
—
202.7
—
0
17
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
25
112
2.27
3.51
1.3
1.3
u/ml
99.6
102.8
—
7
25
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
6
10.06
3.50
1.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
6
6
10.06
3.50
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
563
0.50
3.50
1.3
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
18
5.04
3.37
3.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
27
3.74
3.36
1.2
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
141
1049
1.42
3.34
1.4
1.3
iu/ml
30.8
31.7
0.03
46
334
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
27
128
2.15
3.33
3.0
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
17
65
2.65
3.32
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
119
859
1.45
3.32
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
71
2.57
3.31
1.2
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
156
2.03
3.29
2.8
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
7
8.62
3.26
2.3
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
143
2.07
3.24
11.1
3.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
35
185
1.93
3.24
6.7
2.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
33
171
1.97
3.23
1.5
1.5
u/l
10.1
8.9
0.19
28
138
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
18
72
2.53
3.23
1.4
1.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
28
3.60
3.20
1.2
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
21
91
2.34
3.19
2.3
3.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
17
67
2.57
3.14
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
26
125
2.12
3.11
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
139
2.05
3.09
1.6
1.7
—
—
—
0
0
(3019977) pH of Arterial blood
11
34
3.27
3.06
4.2
5.0
ph
7.4
7.4
—
6
7
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
34
3.27
3.06
1.2
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
16
5.04
3.05
1.3
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
168
1.94
3.04
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
113
2.16
3.03
1.5
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
29
148
2.00
2.98
8.5
7.6
mmol/l
103.7
105.5
1.16
22
135
(3039000) Anion gap in Blood
29
148
2.00
2.98
8.5
7.6
mmol/l
12.5
11.4
0.51
22
135
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
5
10.05
2.98
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
63
2.57
2.97
1.0
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
24
114
2.14
2.97
2.2
1.8
—
—
—
0
0
(4010399)
68
448
1.57
2.94
1.5
1.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
11
35
3.17
2.94
1.4
2.3
%
92.4
97.1
0.16
11
35
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
35
3.17
2.94
1.2
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
561
6033
0.77
2.92
4.2
3.9
mmol/l
1.3
1.3
0.82
499
5512
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
73
490
1.54
2.91
4.1
3.4
mmol/l
1.2
1.2
1.01
66
425
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
157
1218
1.36
2.89
4.8
3.8
ng/l
448.0
378.5
0.10
118
954
(4015189)
9
22
4.13
2.88
5.0
2.6
—
—
—
0
0
(4062490)
16
64
2.53
2.88
1.3
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
9
6.71
2.87
1.3
2.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
476
1.54
2.85
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
13
47
2.80
2.82
1.4
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
90
2.25
2.82
1.4
1.6
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
71
2.42
2.81
1.2
1.3
nmol/l
0.5
0.6
0.20
17
63
(3007930) Methemoglobin/Hemoglobin.total in Blood
45
270
1.71
2.81
7.0
5.6
%
0.8
0.9
1.09
38
255
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
366
0.45
2.78
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
144
1109
1.36
2.77
2.0
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
35
196
1.82
2.76
1.5
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
5
6
8.38
2.75
1.4
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
37
619
0.58
2.75
1.2
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
237
1964
1.29
2.74
4.4
3.1
mmol/l
6.2
7.8
7.19
191
1621
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
14
5.03
2.73
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
172
1367
1.33
2.69
1.3
1.3
u/ml
1.4
2.3
0.65
37
367
(3043410) Blood group antigens tested for on Red Blood Cells
8
19
4.24
2.68
1.4
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
19
4.24
2.68
1.1
1.1
miu/ml
1381.9
1745.3
—
8
19
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
135
1.96
2.58
1.8
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
20
4.03
2.57
6.1
2.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
202
1652
1.30
2.56
3.1
2.6
umol/l
1439.8
7090.3
2.97
172
1426
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
120
909
1.38
2.56
1.8
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
76
530
1.48
2.55
7.3
3.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
31
172
1.83
2.53
1.5
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
675
6396
1.35
2.49
34.7
14.1
mg/l
28.1
24.5
2.10
601
5053
(3023103) Potassium [Moles/volume] in Serum or Plasma
689
6550
1.37
2.48
35.4
16.4
mmol/l
4.0
4.0
0.45
676
6359
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
110
2.03
2.43
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
34
2.97
2.42
2.7
3.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
687
6534
1.36
2.41
35.5
16.3
mmol/l
139.0
139.7
7.83
675
6354
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
129
999
1.35
2.40
1.3
1.3
u/ml
25.1
12.2
0.57
40
382
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
64
2.37
2.40
1.3
1.3
nmol/l
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
21
104
2.05
2.38
1.1
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
21
104
2.05
2.38
1.5
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
8
6.28
2.37
1.2
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
8
22
3.66
2.37
1.9
3.3
u/l
210.4
209.1
—
8
22
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
108
816
1.37
2.35
2.1
1.8
%
1.7
1.5
1.52
99
720
(3026389) Candida sp identified in Specimen by Organism specific culture
17
78
2.21
2.32
1.2
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
469
4268
1.24
2.31
4.1
3.1
u/l
63.3
50.6
1.67
440
4002
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
10
35
2.88
2.31
2.3
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
36
216
1.70
2.29
2.8
3.4
g/l
0.3
0.3
0.17
14
94
(3011648) Oxygen content in Venous blood
13
53
2.48
2.28
1.3
2.3
%
11.0
10.4
0.17
13
53
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
513
4718
1.24
2.27
4.1
3.8
pmol/l
15.1
14.8
2.00
463
4265
(3008536) Aspergillus sp Ab [Presence] in Serum
7
18
3.91
2.25
3.6
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
103
779
1.37
2.23
8.2
7.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
94
2.05
2.17
1.8
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
22
115
1.94
2.17
12.8
2.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
24
130
1.87
2.14
1.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
123
1.90
2.13
1.4
1.2
u/ml
324.7
259.8
0.40
15
68
(3020891) Body temperature
38
238
1.63
2.08
9.6
4.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
32
192
1.69
2.06
9.5
3.5
mmol/l
4.0
3.9
0.18
26
177
(40768804) Tissue Pathology biopsy report
280
2437
1.23
2.04
2.2
2.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
26
3.10
2.01
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
38
2.65
2.01
1.1
1.3
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
13
57
2.30
1.98
1.5
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
84
2.05
1.96
1.5
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
98
1.96
1.96
1.6
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
11
45
2.46
1.93
2.3
1.5
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
33
2.75
1.93
2.8
2.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
43
285
1.54
1.88
5.6
3.8
%
50.7
49.0
0.18
43
280
(4198724)
8
28
2.88
1.86
2.1
1.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
10
40
2.52
1.84
13.4
2.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
12
4.19
1.82
1.8
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
29
2.78
1.79
1.6
1.1
iu/ml
390.1
138.6
—
8
29
(3051611) Lipemic interference index of Serum or Plasma
13
60
2.19
1.78
11.3
2.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
88
1.95
1.76
2.5
2.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
18
3.35
1.75
1.2
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
6
18
3.35
1.75
2.5
1.2
mmol/l
-0.1
2.9
—
6
18
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
110
1.84
1.74
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
61
2.15
1.72
1.0
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
13
3.86
1.71
2.6
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
13
3.86
1.71
1.4
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
71
530
1.37
1.71
4.7
3.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
27
164
1.67
1.70
1.2
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
62
2.11
1.66
2.8
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
62
2.11
1.66
2.8
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
62
2.11
1.66
2.8
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
222
1923
1.21
1.65
4.0
4.0
mg/mmol
13.8
9.3
0.79
145
1217
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
225
0.48
1.65
2.0
1.9
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
26
2.71
1.58
1.3
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
50
2.22
1.57
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
50
2.22
1.57
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
50
2.22
1.57
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
24
145
1.68
1.55
1.4
1.6
e6/l
6908.3
12640.7
0.64
18
107
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
99
789
1.29
1.54
4.6
4.4
%
31.7
31.5
0.06
68
523
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
225
1.53
1.54
1.2
1.4
iu/l
28.5
27.7
0.05
28
187
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
33
2.44
1.54
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
33
2.44
1.54
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
27
169
1.62
1.54
1.5
1.3
—
—
—
0
0
(1002224) Polysomnography panel
15
270
0.55
1.53
1.1
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
27
2.61
1.51
3.9
2.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
27
2.61
1.51
1.1
2.8
—
63344.7
—
0
7
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
27
2.61
1.51
3.9
2.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
51
2.17
1.51
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
51
2.17
1.51
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
51
2.17
1.51
1.1
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
52
377
1.41
1.50
1.4
1.3
u/ml
215.4
161.7
0.25
46
343
(3012441) Differential panel - Pleural fluid
14
72
1.96
1.49
1.8
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
102
1.78
1.45
1.3
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
28
2.51
1.45
3.9
2.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.1
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
7
28
2.51
1.45
1.3
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
208
1812
1.20
1.45
3.3
3.2
mg/l
75.8
306.4
1.79
139
1163
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
164
1.60
1.45
3.5
2.1
u/l
1152.2
1476.8
0.17
12
63
(3005570) Glucose [Moles/volume] in Urine
12
59
2.05
1.44
2.9
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
16
3.14
1.44
1.6
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
88
1.83
1.42
1.1
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
602
5739
1.20
1.41
5.2
4.5
mu/l
1.8
2.1
0.92
549
5210
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
23
2.62
1.37
2.8
5.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
26
167
1.58
1.36
3.7
2.9
—
—
—
0
0
(4306422)
16
90
1.79
1.33
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
54
2.05
1.33
1.1
1.1
u/ml
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
24
152
1.60
1.33
1.3
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
150
0.46
1.32
1.1
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
18
2.79
1.28
2.6
2.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
17
99
1.73
1.28
1.6
2.6
u/ml
337.0
46.7
0.40
17
94
(3044007) Cell count panel - Peritoneal fluid
5
19
2.64
1.21
1.0
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
15
87
1.74
1.15
2.4
2.8
mmol/l
101.9
105.0
0.89
15
87
(3041354) Potassium [Moles/volume] in Venous blood
15
87
1.74
1.15
2.4
2.8
mmol/l
4.3
4.0
1.20
15
87
(3027456) Digoxin [Moles/volume] in Serum or Plasma
19
118
1.62
1.15
3.2
3.2
nmol/l
0.9
0.9
0.00
14
93
(3004616) Nuclear Ab [Presence] in Serum
13
72
1.82
1.15
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
8
39
2.06
1.15
4.6
2.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
20
2.51
1.15
4.2
2.8
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
26
175
1.50
1.14
4.6
4.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
26
175
1.50
1.14
1.3
1.4
miu/ml
185.5
226.6
0.25
11
82
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
103
1.66
1.13
3.4
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
28
192
1.47
1.13
2.1
1.6
iu/ml
1.1
32.5
—
10
37
(3044941) Cell count panel - Synovial fluid
15
88
1.72
1.12
1.6
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
175
1981
0.85
1.11
3.5
4.2
%
19.8
21.3
0.53
69
930
(3002256) Pathology report gross observation
94
779
1.23
1.10
1.3
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
203
1.44
1.06
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
19
121
1.58
1.06
1.1
1.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
22
2.28
1.03
3.2
3.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
9
49
1.85
0.99
1.0
1.0
mg/l
311.2
281.3
—
9
42
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
23
2.18
0.98
1.0
1.3
%
7.4
1.3
—
5
16
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.3
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
20
133
1.52
0.95
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
183
1.43
0.95
1.4
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
183
1.43
0.95
1.4
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
64
518
1.26
0.94
1.6
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
7
37
1.90
0.94
1.4
1.2
u/l
28.9
14.3
—
7
31
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
37
1.90
0.94
2.1
3.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
27
2.23
0.93
1.2
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
13
78
1.68
0.92
1.8
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
156
1382
1.16
0.90
5.0
4.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
103
0.48
0.89
1.4
1.5
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
29
2.08
0.89
2.8
2.3
ug/l
22.0
307.0
—
6
24
(42529406) Shigella sp [Presence] in Stool by Culture
26
186
1.41
0.88
1.4
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
87
1.62
0.88
2.5
2.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
95
1.59
0.88
1.2
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
27
195
1.40
0.87
3.0
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
6
30
2.01
0.87
1.3
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
126
1433
0.86
0.86
2.8
2.9
ug/l
0.6
0.8
1.24
86
936
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
104
1.55
0.85
1.1
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
30
222
1.37
0.85
10.0
2.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
31
1.94
0.84
9.7
6.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
189
1.39
0.82
11.1
1.9
—
—
—
0
0
(3000012) Reticulocyte production index
6
32
1.88
0.82
1.2
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
14
90
1.57
0.78
1.2
1.2
u/ml
4.2
4.4
—
5
27
(3003740) Influenza virus B Ag [Presence] in Specimen
5
98
0.51
0.78
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
53
1.71
0.75
1.2
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
615
5970
1.13
0.75
26.4
12.9
ml/min/173m2
88.1
81.2
8.80
546
4926
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
67
1.65
0.75
1.2
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
55
1.64
0.73
1.1
2.3
—
—
—
0
0
(4211845)
5
25
2.01
0.72
3.2
2.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
56
1.61
0.72
2.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
40
1.76
0.71
2.7
3.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
48
584
0.81
0.70
2.0
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
700
7125
0.86
0.69
43.0
20.7
g/l
129.8
136.1
20.51
692
7012
(3010813) Leukocytes [#/volume] in Blood
700
7125
0.86
0.69
42.8
20.6
e9/l
7.0
6.7
3.40
689
6923
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
512
1.21
0.69
3.1
2.7
ml/min/173m2
71.0
65.4
0.49
34
216
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
69
1.60
0.68
4.1
3.7
—
—
—
0
0
(4146454)
11
69
1.60
0.68
3.8
2.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
27
1.86
0.68
1.6
1.2
mmol/l
5.3
6.8
—
5
27
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
5
27
1.86
0.68
1.0
1.3
%
55.0
61.9
—
5
17
(3023511) Choriogonadotropin [Units/volume] in Urine
15
102
1.48
0.68
1.7
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
700
7123
0.86
0.67
42.7
20.6
e12/l
4.4
4.5
9.32
688
6921
(3035941) MCH [Entitic mass]
700
7122
0.87
0.67
42.5
20.5
pg
29.9
30.4
7.24
693
7011
(3025941) Bacteria identified in Stool by Culture
41
331
1.25
0.66
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
700
7121
0.87
0.66
42.6
20.5
fl
90.6
91.0
1.67
692
7011
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
598
6140
0.90
0.66
4.8
4.5
mmol/l
5.9
6.0
0.10
534
5572
(3017446) Testosterone [Moles/volume] in Serum or Plasma
64
544
1.19
0.64
2.4
2.2
nmol/l
11.9
13.1
0.47
56
482
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
130
0.61
0.64
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
130
0.61
0.64
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
130
0.61
0.64
1.4
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
130
0.61
0.64
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
30
234
1.29
0.63
10.0
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
700
7118
0.87
0.63
42.9
20.6
e9/l
254.9
246.7
2.12
689
6933
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
16
223
0.71
0.63
1.4
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
96
1.47
0.61
1.1
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
156
1.36
0.61
2.1
1.8
iu/l
4.4
6.1
0.28
11
51
(3022145) Colonoscopy Study observation
80
698
1.16
0.60
1.3
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
21
0.00
0.60
0.0
1.1
—
8.5
—
0
21
(3028300) Cannabinoids [Presence] in Urine
30
237
1.28
0.59
10.2
2.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
64
1.57
0.58
1.5
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
76
663
1.16
0.57
2.3
4.3
ug/l
408.4
26.5
0.47
59
550
(3049717) Cytology report of Urine Cyto stain
34
274
1.25
0.57
2.3
2.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
54
1.49
0.57
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
54
1.49
0.57
1.3
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
23
177
1.31
0.55
1.8
1.4
ug/g
244.1
287.2
0.56
17
97
(3044889) 12 lead EKG panel
460
4436
1.09
0.55
4.0
3.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
38
1.58
0.54
3.0
1.9
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
516
5312
0.92
0.53
36.0
17.1
%
14.2
13.7
9.65
508
5203
(3002523) Influenza virus A Ag [Presence] in Specimen
6
98
0.61
0.52
1.2
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
40
1.50
0.51
1.2
1.2
—
—
—
0
0
(4268621)
9
64
1.41
0.51
2.3
2.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
185
1721
1.10
0.51
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
108
0.65
0.49
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
108
0.65
0.49
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
51
591
0.85
0.48
1.3
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
29
235
1.24
0.48
10.9
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
111
0.63
0.48
1.4
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
677
6658
1.11
0.47
26.7
13.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
18
139
1.30
0.44
10.4
4.0
mg/l
24.7
27.5
0.19
11
89
(40768443) Skin Pathology biopsy report
32
266
1.21
0.44
1.2
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
70
1.43
0.42
3.1
2.4
—
—
—
0
0
(4094501)
12
161
0.74
0.41
1.1
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
15
0.00
0.41
0.0
7.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.1
—
17.8
—
0
15
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.9
—
2.0
—
0
8
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
15
0.00
0.41
0.0
3.7
—
34.2
—
0
5
(44790047)
11
79
1.40
0.41
2.8
1.5
—
—
—
0
0
(44790049)
11
79
1.40
0.41
2.8
1.5
—
—
—
0
0
(44806118)
11
79
1.40
0.41
2.8
1.5
—
—
—
0
0
(44790048)
11
79
1.40
0.41
2.8
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
60
1.34
0.40
1.5
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
313
0.82
0.39
1.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
307
1.18
0.39
1.9
2.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
136
0.73
0.38
1.6
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
135
0.74
0.36
1.3
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
236
1.19
0.35
10.3
2.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
46
1.31
0.33
1.3
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
90
0.66
0.33
1.7
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
577
5870
0.94
0.32
31.1
15.1
%
38.6
40.1
3.06
371
4209
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
60
655
0.91
0.27
2.0
2.0
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
9
72
1.25
0.25
1.1
1.4
nmol/l
0.2
0.4
—
9
57
(3048689) Calprotectin [Mass/mass] in Stool
80
744
1.08
0.25
2.0
2.4
ug/g
110.2
120.8
0.20
60
604
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
76
816
0.92
0.24
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
180
1.17
0.24
1.7
1.8
—
—
—
0
0
(3000492) Spirometry study
58
629
0.92
0.23
1.6
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
5
38
1.32
0.23
3.0
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
97
1.24
0.23
1.2
1.2
u/ml
5.0
4.0
—
5
38
(44813793)
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.0
—
17.4
—
0
10
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
161
1676
0.95
0.21
1.6
1.7
mmol/l
1.6
1.4
1.29
139
1400
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
12
0.00
0.21
0.0
8.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
12
0.00
0.21
0.0
3.1
—
6246.8
—
0
12
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
239
2462
0.96
0.20
4.6
4.8
ug/l
4.0
2.4
0.49
210
2186
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
407
3994
1.04
0.20
3.4
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
65
695
0.93
0.20
1.6
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
174
1.15
0.20
2.0
2.4
ug/min
114.0
96.5
0.08
13
99
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
61
1.15
0.17
1.4
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
7
62
1.13
0.17
1.1
1.1
nmol/l
1.2
1.6
—
7
55
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
215
1.12
0.16
1.5
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
158
1.14
0.16
1.6
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
15
170
0.88
0.13
1.3
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
109
1052
1.04
0.13
1.7
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
27
248
1.09
0.13
1.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
293
0.92
0.12
1.1
1.1
—
125.1
—
0
11
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
95
1.16
0.11
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
143
1.12
0.11
1.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
147
0.88
0.11
2.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
29
312
0.93
0.11
1.4
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
96
1.15
0.10
1.2
1.1
—
—
—
0
0
(4034850)
18
197
0.91
0.10
11.5
11.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
678
6811
0.97
0.09
15.4
10.2
u/l
26.9
27.0
0.02
655
6569
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
390
0.95
0.09
1.3
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
65
1.08
0.08
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
74
1.08
0.07
1.3
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
122
0.90
0.07
1.4
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
163
0.92
0.07
1.5
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
582
5845
0.98
0.05
6.5
5.7
mmol/mol
39.8
40.0
0.10
537
5395
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
43
417
1.03
0.04
1.2
1.2
iu/ml
114.5
159.0
0.25
17
174
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
101
1.09
0.04
1.3
1.1
u/ml
0.8
1.9
—
5
40
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
31
321
0.96
0.03
2.6
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
29
297
0.98
0.01
1.6
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
26
258
1.01
0.00
2.3
1.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
8
0.00
0.00
0.0
5.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
62
0.97
0.00
1.3
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
60
1.00
0.00
1.3
1.7
—
—
—
0
0
(3025315) Body weight
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
5.7
—
6.5
—
0
9
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.1
—
75.8
—
0
9
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
9
0.00
0.00
0.0
5.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_PARDIPLE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PARDIPLE | 3.284 [2.85, 3.78] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.022 |
During the follow-up period (1.1.1998 — 31.12.2019), 1018 out of 2755 females with G6_PARDIPLE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PARDIPLE | 3.353 [2.93, 3.84] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 1463 out of 3289 males with G6_PARDIPLE died.
Mortality risk
Mortality risk for people of age
years, who have G6_PARDIPLE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.264% | 0.544% |
| 5 | 1.408% | 3.501% |
| 10 | 3.74% | 7.817% |
| 15 | 7.163% | 14.977% |
| 20 | 12.565% | 24.983% |
Relationships between endpoints
↥Index endpoint: G6_PARDIPLE – Paraplegia, diplegia of upper limbs
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data